​

Autolus Therapeutics Ownership | Who Owns Autolus Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Autolus Therapeutics Ownership Summary


Autolus Therapeutics is owned by 49.67% institutional investors, 18.09% insiders, and 32.24% retail investors. Mak capital one is the largest institutional shareholder, holding 12.63% of AUTL shares. Syncona Ord is the top mutual fund, with 11.55% of its assets in Autolus Therapeutics shares.

AUTL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAutolus Therapeutics49.67%18.09%32.24%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Mak capital one33.62M12.63%$46.40M
Blackstone20.49M7.70%$28.27M
Syncona portfolio16.64M6.25%$32.28M
Armistice capital15.80M5.94%$21.80M
Tfg asset management gp9.50M3.57%$13.11M
Schroder investment management group9.49M3.57%$12.05M
Blackrock4.44M2.00%$15.44M
Frazier life sciences management4.45M1.67%$6.14M
Axa investment managers3.36M1.26%$5.48M
Bnp paribas asset management3.36M1.26%$6.52M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Syncona portfolio16.64M100.00%$32.28M
Mak capital one33.62M6.84%$46.40M
Tfg asset management gp9.50M2.55%$13.11M
Armistice capital15.80M0.39%$21.80M
Nano cap new millennium growth fund l p150.00K0.21%$291.00K
Privium fund management b.v.469.49K0.18%$910.81K
Frazier life sciences management4.45M0.16%$6.14M
Edentree asset management300.00K0.12%$414.00K
Blackstone20.49M0.11%$28.27M
Laurion capital management lp3.32M0.10%$6.43M

Top Buyers

HolderShares% AssetsChange
Mak capital one33.62M6.84%3.62M
Axa investment managers3.36M0.01%3.36M
Walleye capital1.21M0.00%1.21M
Balyasny asset management971.69K0.00%971.69K
Morgan stanley2.11M0.00%844.70K

Top Sellers

HolderShares% AssetsChange
Wellington management group llp---27.15M
Avoro capital advisors---9.91M
Fmr---7.11M
Cormorant asset management, lp---6.62M
Paradigm biocapital advisors lp---6.43M

New Positions

HolderShares% AssetsChangeValue
Axa investment managers3.36M0.01%3.36M$5.48M
Walleye capital1.21M0.00%1.21M$2.36M
Balyasny asset management971.69K0.00%971.69K$1.34M
Marex group542.86K0.00%542.86K$749.14K
Toroso investments273.62K0.00%273.62K$530.82K

Sold Out

HolderChange
Huntington national bank-1.00
Principal securities-37.00
Us bancorp \de\-64.00
Cornerstone planning group-100.00
Eversource wealth advisors-163.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202686-1.15%132,206,376-1.66%491.95%3811.76%20-25.93%
Mar 31, 202627-70.65%3,529,975-97.47%10.05%12-70.73%7-73.08%
Dec 31, 202524-75.76%20,150,499-86.07%70.26%8-82.98%8-68.00%
Sep 30, 202532-66.32%22,001,645-86.74%80.21%8-84.31%14-50.00%
Jun 30, 202593-2.11%165,894,0399.60%621.93%4925.64%27-15.63%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Syncona Ord30.73M11.55%9.39M
Vanguard Health Care Inv19.36M7.27%-
International Biotechnology Ord6.53M2.45%-686.64K
FIAM Small Cap Core CIT Cl B4.02M1.51%946.70K
AXA Framlington Health Fund - R Income3.36M1.26%-
FIAM Small Cap Core Composite3.14M1.18%-26.57K
Fidelity Small Cap Growth2.57M0.97%-
US Small-Cap Growth II Equity Comp2.02M0.76%-216.32K
Wellington Global Hlthcr Eq USD G Ac1.79M0.67%-
Fidelity Stock Selector Small Cap1.62M0.61%-348.11K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 02, 2026Piccina Cintia U.S. CCO & Country Gen ManagerSell$15.68K

Insider Transactions Trends


DateBuySell
2026 Q3-1
2026 Q2--
2026 Q1--

AUTL Ownership FAQ


Who Owns Autolus Therapeutics?

Autolus Therapeutics shareholders are primarily institutional investors at 49.67%, followed by 18.09% insiders and 32.24% retail investors. The average institutional ownership in Autolus Therapeutics's industry, Biotech Stocks , is 385.89%, which Autolus Therapeutics falls below.

Who owns the most shares of Autolus Therapeutics?

Autolus Therapeutics’s largest shareholders are Mak capital one (33.62M shares, 12.63%), Blackstone (20.49M shares, 7.70%), and Syncona portfolio (16.64M shares, 6.25%). Together, they hold 26.58% of Autolus Therapeutics’s total shares outstanding.

Does Blackrock own Autolus Therapeutics?

Yes, BlackRock owns 2.00% of Autolus Therapeutics, totaling 4.44M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 15.44M$. In the last quarter, BlackRock increased its holdings by 380.18K shares, a 9.37% change.

Who is Autolus Therapeutics’s biggest shareholder by percentage of total assets invested?

Syncona portfolio is Autolus Therapeutics’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 16.64M Autolus Therapeutics shares, valued at 32.28M$.

Who is the top mutual fund holder of Autolus Therapeutics shares?

Syncona Ord is the top mutual fund holder of Autolus Therapeutics shares, with 11.55% of its total shares outstanding invested in 30.73M Autolus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools